Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FJGFN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 80 mg tablets (60-count units) under contract number 4569035597. The award, valued at $4,169.59 with a firm fixed-price structure, was executed on August 8, 2025, with an ultimate completion date of August 11, 2025. This delivery order carries no set-aside designation and represents a continuation of DMS Pharmaceutical Group's established relationship with the Defense Logistics Agency in supplying pharmaceutical products to federal healthcare systems.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency through the SPE2DB program, a $499.9 billion single-award vehicle valid through November 2026. The IDC authorizes firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical items, including branded and generic prescription drugs, biologics, and medical consumables across multiple product categories. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides direct distribution of prescription medications and pharmacy services to Department of Defense healthcare facilities worldwide, with this particular order fulfilling oncology treatment requirements for military health operations.
Quick answers
Who was awarded contract SPE2DB25FJGFN?
SPE2DB25FJGFN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FJGFN worth?
The government has obligated $4,170 on SPE2DB25FJGFN.
Is contract SPE2DB25FJGFN an order under another contract?
Yes. SPE2DB25FJGFN is a delivery order under SPE2DB24D9224, an indefinite delivery contract.
Was contract SPE2DB25FJGFN competed?
The extent of competition for SPE2DB25FJGFN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award